ZEBRA TECHNOLOGIES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Zebra Technologies Corporation - (ZBRA)


NEW ORLEANS, Aug. 11, 2017 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 25, 2017 to file lead plaintiff applications in a securities class action lawsuit against Zebra Technologies Corporation (NasdaqGS:ZBRA), if they purchased the Company’s shares between March 17, 2015 and May 9, 2016, inclusive (the “Class Period”).  This action is pending in the United States District Court for the Eastern District of New York.

Get Help

Zebra Technologies investors should visit us at https://www.claimsfiler.com/cases/view-zebra-technologies-corporation-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.  

About the Lawsuit

Zebra Technologies and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On May 10, 2016, Zebra announced that its Q1 2016 financial results were “below . . . expectations, with lower sales and earnings reflecting the continuation of a cautious enterprise spending environment.”  However, that same day, Zebra revealed that problems had been identified in its internal controls in 2015 that had impacted its ability to accurately forecast its pretax income and deferred taxes.

On this news, the price of Zebra’s shares plummeted more than $11 per share.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.

To learn more about ClaimsFiler, visit www.claimsfiler.com.